- Home
- SNTI vs GFAI Comparison
SNTI vs GFAI Comparison
Compare SNTI & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- GFAI
- Stock Information
- Founded
- SNTI 2016
- GFAI 2018
- Country
- SNTI United States
- GFAI Singapore
- Employees
- SNTI N/A
- GFAI N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- GFAI Diversified Commercial Services
- Sector
- SNTI Health Care
- GFAI Consumer Discretionary
- Exchange
- SNTI Nasdaq
- GFAI Nasdaq
- Market Cap
- SNTI 17.8M
- GFAI 20.7M
- IPO Year
- SNTI N/A
- GFAI N/A
- Fundamental
- Price
- SNTI $3.20
- GFAI $0.99
- Analyst Decision
- SNTI Strong Buy
- GFAI Strong Buy
- Analyst Count
- SNTI 1
- GFAI 2
- Target Price
- SNTI $12.00
- GFAI $6.75
- AVG Volume (30 Days)
- SNTI 27.8K
- GFAI 345.1K
- Earning Date
- SNTI 05-08-2025
- GFAI 04-28-2025
- Dividend Yield
- SNTI N/A
- GFAI N/A
- EPS Growth
- SNTI N/A
- GFAI N/A
- EPS
- SNTI N/A
- GFAI N/A
- Revenue
- SNTI N/A
- GFAI $35,841,743.00
- Revenue This Year
- SNTI N/A
- GFAI $0.37
- Revenue Next Year
- SNTI N/A
- GFAI $5.60
- P/E Ratio
- SNTI N/A
- GFAI N/A
- Revenue Growth
- SNTI N/A
- GFAI 1.78
- 52 Week Low
- SNTI $1.52
- GFAI $0.94
- 52 Week High
- SNTI $16.94
- GFAI $4.20
- Technical
- Relative Strength Index (RSI)
- SNTI 44.14
- GFAI 37.96
- Support Level
- SNTI $3.33
- GFAI $1.08
- Resistance Level
- SNTI $3.63
- GFAI $1.25
- Average True Range (ATR)
- SNTI 0.33
- GFAI 0.07
- MACD
- SNTI 0.01
- GFAI 0.01
- Stochastic Oscillator
- SNTI 25.36
- GFAI 15.15
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About GFAI Guardforce AI Co. Limited
Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.